Evaxion Biotech AS (EVAX)
$1.23 -$0.06 (-4.65%) 10:06 AM 12/11/24
NASDAQ | $USD | BiotechnologyStock Data
-
Market Cap
$13.28M -
Day's Range
$1.20 - $1.30 -
Volume
34,973 -
52 Week Low / High
$1.28 - $13.61 -
PE Ratio
- -
PEG Ratio
- -
Dividend Frequency
-
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
- 1
- Strong Buy
- 1
- Buy
- 0
- Hold
- 0
- Sell
- 0
- Strong Sell
- $9.33
- Target Price
Company News
-
EVAX Process Continues to Garner Interest and Investment — Sep 26th, 2024
By Brad Sorensen, CFA NASDAQ:EVAX READ THE FULL EVAX RESEARCH REPORT Evaxion (NASDAQ:EVAX) is a clinical stage company that is making AI useful in the current environment by using the technology to develop new cancer-fighting vaccines. The company notes that it has demonstrated that it ...
-
EVAX Process Continues to Garner Interest and Investment — Sep 26th, 2024
By Brad Sorensen, CFA NASDAQ:EVAX READ THE FULL EVAX RESEARCH REPORT Evaxion (NASDAQ:EVAX) is a clinical stage company that is making AI useful in the current environment by using the technology to develop new cancer-fighting vaccines. The company notes that it has demonstrated that it ...
-
EVAX Process Continues to Garner Interest and Investment — Sep 26th, 2024
By Brad Sorensen, CFA NASDAQ:EVAX READ THE FULL EVAX RESEARCH REPORT Evaxion (NASDAQ:EVAX) is a clinical stage company that is making AI useful in the current environment by using the technology to develop new cancer-fighting vaccines. The company notes that it has demonstrated that it ...
Similar Stocks
Portfolio
Comprised of 1 portfolios